Literature DB >> 7189163

Brucella septicemia in pregnancy.

P Schreyer, E Caspi, Y Leiba, Y Eshchar, D Sompolinsky.   

Abstract

A case of Brucella melitensis septicemia in a second-trimester pregnancy causing intrauterine fetal death and Gram-negative septic shock with diffuse intravascular coagulation is reported. The literature is reviewed. This is the first reported case of human brucellosis in association with Gram-negative sepsis and DIC during pregnancy. The importance of blood cultures and agglutinins for Brucella in febrile pregnant patients is re-emphasized.

Entities:  

Mesh:

Year:  1980        PMID: 7189163     DOI: 10.1016/0028-2243(80)90087-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  [Brucellosis with fatal endotoxic shock].

Authors:  S Kress; P Klooker; V Kaufmann; N Sloot; J F Riemann; H Brass
Journal:  Med Klin (Munich)       Date:  1997-09-15

2.  Haematological manifestations of childhood brucellosis.

Authors:  Y al-Eissa; M al-Nasser
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

3.  A case of disseminated intravascular coagulation caused by Brucella melitensis.

Authors:  Tuba Turunc; Yusuf Ziya Demiroglu; Ebru Kizilkilic; Hikmet Aliskan; Can Boga; Hande Arslan
Journal:  J Thromb Thrombolysis       Date:  2007-06-12       Impact factor: 2.300

4.  Human Brucellosis and Adverse Pregnancy Outcomes.

Authors:  Angela M Arenas-Gamboa; Carlos A Rossetti; Sankar P Chaki; Daniel G Garcia-Gonzalez; Leslie G Adams; Thomas A Ficht
Journal:  Curr Trop Med Rep       Date:  2016-10-01

Review 5.  Different Clinical Manifestations of Human Brucellosis in Pregnant Women: A Systematic Scoping Review of 521 Cases from 10 Countries.

Authors:  Zhe Liu; Dawei Wei; Yanjun Li; Hao Zhou; Desheng Huang; Peng Guan
Journal:  Infect Drug Resist       Date:  2020-04-14       Impact factor: 4.003

Review 6.  Human brucellosis in pregnancy - an overview.

Authors:  Mile Bosilkovski; Jurica Arapović; Fariba Keramat
Journal:  Bosn J Basic Med Sci       Date:  2020-11-02       Impact factor: 3.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.